Obstetrics and gynecology
-
Obstetrics and gynecology · Sep 2002
Practice Guideline GuidelineACOG Committee Opinion: Number 275, September 2002. Obstetric management of patients with spinal cord injuries.
Effective rehabilitation and modern reproductive technology may increase the number of women considering pregnancy who have spinal cord injuries (SCIs). It is important that obstetricians caring for these patients are aware of the specific problems related to SCIs. Autonomic dysreflexia is the most significant medical complication seen in women with SCIs, and precautions should be taken to avoid stimuli that can lead to this potentially fatal syndrome. Women with SCIs may give birth vaginally, but when cesarean delivery is indicated, adequate anesthesia (spinal or epidural if possible) is needed.
-
Obstetrics and gynecology · Aug 2002
Randomized Controlled Trial Comparative Study Clinical TrialValdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea.
To compare the efficacy of the cyclooxygenase (COX)-2-specific inhibitor valdecoxib with naproxen sodium in treating menstrual pain associated with primary dysmenorrhea. ⋯ Both valdecoxib 20- and 40-mg doses were effective and well tolerated for the treatment of primary dysmenorrhea. Valdecoxib 20 mg and 40 mg demonstrate analgesic efficacy, based on onset, magnitude, and duration of analgesia that is similar to naproxen sodium, making it a potential choice for treating women with primary dysmenorrhea.
-
Obstetrics and gynecology · Jul 2002
Comparative StudyPrenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis.
To assess the association between prenatal antibiotics, including erythromycin, and infantile hypertrophic pyloric stenosis in a large cohort of infants. ⋯ The hypothesized association between erythromycin and infantile pyloric stenosis was not seen. Causal inference from the association between prenatal nonerythromycin macrolides and infantile hypertrophic pyloric stenosis is limited by the small number of affected children and the evidence of other differences between users of nonerythromycin macrolides and controls.